Kindred Biosciences downgraded by Lake Street with a new price target
$KIN
Major Pharmaceuticals
Health Care
Lake Street downgraded Kindred Biosciences from Buy to Hold and set a new price target of $9.25 from $12.00 previously
Save time and jump to the most important pieces.